UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 337

Sortiert nach

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005-1014

2014

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients

Journal of thrombosis and thrombolysis, 2014, Vol.38 (2), p.127-136

2014

Volltextzugriff (PDF)

A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Clinical cancer research, 2019-09, Vol.25 (17), p.5202-5211

2019

Volltextzugriff (PDF)

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine

Cephalalgia, 2020-08, Vol.40 (9), p.978-989

2020

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

Population Pharmacokinetic and Exposure–Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia

Clinical pharmacokinetics, 2018-02, Vol.57 (2), p.243-254

2018

Volltextzugriff (PDF)

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.112 (3), p.589

2014

Volltextzugriff (PDF)

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

Investigational new drugs, 2015-06, Vol.33 (3), p.710-719

2015

Volltextzugriff (PDF)

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Thrombosis research, 2014-09, Vol.134 (3), p.552-557

2014

Volltextzugriff (PDF)

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Thrombosis and haemostasis, 2014, Vol.111 (5), p.943

2014

Volltextzugriff (PDF)

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Journal of pediatric hematology/oncology, 2015-01, Vol.37 (1), p.1-9

2015

Volltextzugriff (PDF)

Impaired Responsiveness to the Platelet P2Y12Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005

2014

Volltextzugriff (PDF)

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Blood, 2012-11, Vol.120 (21), p.3213-3213

2012

Volltextzugriff (PDF)

Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

Journal of the American College of Cardiology, 2013, Vol.62 (7), p.577

2013

Volltextzugriff (PDF)

Abstract 1439: Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasugrel

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

The Beauty and the Boost: A Higgs Boson Tale: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Moser, Brian

2023

Volltextzugriff (PDF)

The Beauty and the Boost: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Moser, Brian

1, 2023

Volltextzugriff (PDF)

Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth

PloS one, 2015-07, Vol.10 (7), p.e0134364-e0134364

2015

Volltextzugriff (PDF)

Phenanthrene‐Fused‐Quinoxaline as a Key Building Block for Highly Efficient and Stable Sensitizers in Copper‐Electrolyte‐Based Dye‐Sensitized Solar Cells

Angewandte Chemie International Edition, 2020-06, Vol.59 (24), p.9324-9329

International ed. in English, 2020

Volltextzugriff (PDF)

Changes in markers of lipid oxidation and thermal treatment in feed‐grade fats and oils

Journal of the science of food and agriculture, 2020-06, Vol.100 (8), p.3328-3340

2020

Volltextzugriff (PDF)

Hitchhiker's Guide to Super-Resolution: Introduction and Recent Advances

IEEE transactions on pattern analysis and machine intelligence, 2023-08, Vol.45 (8), p.9862-9882

2023

Volltextzugriff (PDF)

The Effect of Hole Transport Material Pore Filling on Photovoltaic Performance in Solid-State Dye-Sensitized Solar Cells

Advanced energy materials, 2011-05, Vol.1 (3), p.407-414

2011

Volltextzugriff (PDF)

Trends and predictors of opioid use after total knee and total hip arthroplasty

Pain (Amsterdam), 2016-06, Vol.157 (6), p.1259

2016

Volltextzugriff (PDF)

1 – 25 von 337

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(295)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Life Sciences & Biomedicine
(137)
Humans
(116)
Female
(74)
Male
(72)
Aged
(50)
Middle Aged
(42)
Biological And Medical Sciences
(36)
Medical Sciences
(33)
Adult
(32)
Physical Sciences
(28)
Animals
(25)
Technology
(25)
Chemistry
(20)
Science & Technology - Other Topics
(20)
Adolescent
(19)
Neurosciences & Neurology
(19)
Environmental Sciences & Ecology
(17)
Multidisciplinary Sciences
(17)
Clinical Neurology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of The American College Of Cardiology
(10)
Biochemistry
(8)
Neurology
(5)
Plos One
(5)
Science
(5)
Biophysical Journal
(4)
Pharmaceutics
(4)
The Journal Of Physical Chemistry. B
(4)
Cancer Research
(3)
Chest
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients: The GENERATIONS Trial, A Pharmacodynamic and Pharmacokinetic Study in Stable Coronary Artery Disease Patients

Population Pharmacokinetic and Exposure–Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease

Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study

Impaired Responsiveness to the Platelet P2Y12Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients

Abstract 1439: Cytochrome P450 Genetic Variants Predict Cardiovascular Outcomes following Treatment with Clopidogrel but not with Prasugrel

The Beauty and the Boost: A Higgs Boson Tale: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

The Beauty and the Boost: Measurements of Higgs Boson Production at High Energy in Decays to Bottom Quarks and Their Interpretations with the ATLAS Experiment at the LHC

Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth

Phenanthrene‐Fused‐Quinoxaline as a Key Building Block for Highly Efficient and Stable Sensitizers in Copper‐Electrolyte‐Based Dye‐Sensitized Solar Cells

Changes in markers of lipid oxidation and thermal treatment in feed‐grade fats and oils

Hitchhiker's Guide to Super-Resolution: Introduction and Recent Advances

The Effect of Hole Transport Material Pore Filling on Photovoltaic Performance in Solid-State Dye-Sensitized Solar Cells

Trends and predictors of opioid use after total knee and total hip arthroplasty

Suchergebnisse filtern